Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Artificial liver device tested in 10 patients with acute liver failure

NCT ID NCT06285253

First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 26 times

Summary

This early-phase study tested a device called miroliverELAP in 10 adults with acute liver failure. The device works outside the body to support the liver for up to 48 hours, giving time for the liver to recover or for a transplant to be found. The main goals were to check safety and survival during treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ALCOHOLIC HEPATITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Cleveland Clinic Foundation

    Cleveland, Ohio, 44195, United States

  • Intermountain Healthcare

    Salt Lake City, Utah, 84103, United States

  • Mayo Clinic

    Rochester, Minnesota, 55902, United States

  • Mount Sinai Recanati/Miller Transplantation Institute

    New York, New York, 10029, United States

  • Northwestern Memorial Hospital

    Chicago, Illinois, 60611, United States

  • University of Michigan Medical School

    Ann Arbor, Michigan, 48109, United States

  • University of Minnesota Medical School

    Minneapolis, Minnesota, 55455, United States

  • Virginia Commonwealth University Medical Center

    Richmond, Virginia, 23970, United States

Conditions

Explore the condition pages connected to this study.